Skip to main content
Fig. 5 | The Journal of Headache and Pain

Fig. 5

From: Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients

Fig. 5

Mean and 95% CI of spectral power of F (5 Hz),2F (10 Hz) and 3F (15 Hz) elicited with 5 Hz stimulation in 13 migraine patients in basal condition (T0), after 1 h galcanezumab (T1) and 3 months galcanezumab (T2). Results of Bonferroni test are shown: T2 vs T0 and T1 * p < 0.05; ** p < 0.01; ++ T2 vs T0 p < 0.01

Back to article page